Patients who use immunomodulators to manage severe inflammatory skin disorders should immediately stop the therapy if they are diagnosed with COVID-19, expert advice suggests. 

“There is little specific evidence of COVID-19 infection being aggravated by immunomodulators as used in otherwise healthy dermatology patients but a precautionary approach is mandated,” a team of New Zealand and Australian dermatologists write in the Australasian Journal of Dermatology.